Abstract
In-depth exploration and characterization of human serum and plasma proteomes is an attractive strategy for the identification of potential prognostic or diagnostic biomarkers. The possibility of analyzing larger numbers of samples in a high-throughput fashion has markedly increased with affinity-based microarrays, thus providing higher statistical power to these biomarker studies. Here, we describe a protocol for high-density serum and plasma reverse phase protein arrays (RPPAs). We demonstrate how a biobank of 12,392 samples was immobilized and analyzed on a single microarray slide, allowing high-quality profiling of abundant target proteins across all samples in one assay.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aguilar-Mahecha A, Hassan S, Ferrario C, Basik M (2006) Microarrays as validation strategies in clinical samples: tissue and protein microarrays. OMICS 10:311–326. doi:10.1089/omi.2006.10.311
Paweletz CP, Charboneau L, Bichsel VE et al (2001) Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20:1981–1989. doi:10.1038/sj.onc.1204265
Caiazzo RJ, Maher AJ, Drummond MP et al (2009) Protein microarrays as an application for disease biomarkers. Proteomics Clin Appl 3:138–147. doi:10.1002/prca.200800149
Ahmed F, Gyorgy A, Kamnaksh A et al (2012) Time-dependent changes of protein biomarker levels in the cerebrospinal fluid after blast traumatic brain injury. Electrophoresis 33:3705–3711. doi:10.1002/elps.201200299
Janzi M, Odling J, Pan-Hammarström Q et al (2005) Serum microarrays for large scale screening of protein levels. Mol Cell Proteomics 4:1942–1947. doi:10.1074/mcp.M500213-MCP200
Janzi M, Sjöberg R, Wan J et al (2009) Screening for C3 deficiency in newborns using microarrays. PLoS One 4:e5321. doi:10.1371/journal.pone.0005321
Aguilar-Mahecha A, Cantin C, O’Connor-McCourt M et al (2009) Development of reverse phase protein microarrays for the validation of clusterin, a mid-abundant blood biomarker. Proteome Sci 7:15. doi:10.1186/1477-5956-7-15
Kobayashi M, Nagashio R, Jiang SX et al (2015) Calnexin is a novel sero-diagnostic marker for lung cancer. Lung Cancer 90:342–345. doi:10.1016/j.lungcan.2015.08.015
Solier C, Langen H (2014) Antibody-based proteomics and biomarker research—current status and limitations. Proteomics 14:774–783. doi:10.1002/pmic.201300334
Ayoglu B, Häggmark A, Neiman M et al (2011) Systematic antibody and antigen-based proteomic profiling with microarrays. Expert Rev Mol Diagn 11:219–234. doi:10.1586/erm.10.110
Akbani R, Carragher N, Goldstein T et al (2014) Realizing the promise of reverse phase protein arrays for clinical, translational and basic research: a workshop report. Mol Cell Proteomics 13:1625–1643
Bordeaux J, Welsh AW, Agarwal S et al (2010) Antibody validation. BioTechniques 48:197–209. doi:10.2144/000113382
Sauer U (2011) Impact of substrates for probe immobilization. In: Korf U (ed) Protein microarrays: methods and protocols, Methods in molecular biology, vol 785. Springer Science+Business Media, LLC: Humana Press, Heidelberg, Germany, pp 363–378
Tighe P, Negm O, Todd I, Fairclough L (2013) Utility, reliability and reproducibility of immunoassay multiplex kits. Methods 61:23–29. doi:10.1016/j.ymeth.2013.01.003
Mcwilliam I, Kwan MC, Hall D (2011) Inkjet printing for the production of protein microarrays. In: Korf U (ed) Protein microarrays: methods and protocols, Methods in molecular biology, vol 785. Springer Science+Business Media, LLC: Humana Press, Heidelberg, Germany, pp 345–361
Tisone TC, Tonkinson JL (2005) Non-contact dispensing for protein microarrays. In: Schena M (ed) Protein microarrays. Jones and Bartlett Publishers, Sudbury, MA, pp 169–185
Magnusson PKE, Almqvist C, Rahman I et al (2013) The Swedish twin registry: establishment of a biobank and other recent developments. Twin Res Hum Genet 16:317–329. doi:10.1017/thg.2012.104
Uhlén M, Björling E, Agaton C et al (2005) A human protein atlas for normal and cancer tissues based on antibody proteomics. Mol Cell Proteomics 4:1920–1932. doi:10.1074/mcp.M500279-MCP200
Acknowledgment
We thank the Swedish Twin Registry for providing the serum samples. We also thank all members of the Plasma Profiling and the Auoimmunity Profiling groups at SciLifeLab, as well as the entire staff of the Human Protein Atlas. This study was funded by grants from Science for Life Laboratory, the Knut and Alice Wallenberg Foundation, and the KTH Center for Applied Proteomics (KCAP) funded by the Erling-Persson Family Foundation. The authors declare no conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer Science+Business Media LLC
About this protocol
Cite this protocol
Hellström, C., Dodig-Crnković, T., Hong, MG., Schwenk, J.M., Nilsson, P., Sjöberg, R. (2017). High-Density Serum/Plasma Reverse Phase Protein Arrays. In: Greening, D., Simpson, R. (eds) Serum/Plasma Proteomics. Methods in Molecular Biology, vol 1619. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7057-5_18
Download citation
DOI: https://doi.org/10.1007/978-1-4939-7057-5_18
Published:
Publisher Name: Humana Press, New York, NY
Print ISBN: 978-1-4939-7056-8
Online ISBN: 978-1-4939-7057-5
eBook Packages: Springer Protocols